Skip to Content

L020 (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint L020 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Lupin Pharmaceuticals, Inc..

Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L020

Rabeprazole Sodium Delayed-Release

Imprint
L020
Strength
20 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
68180-0220

Get help with Imprint Code FAQs.

Related Images for "L020"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.